Drugging the Undruggable

Cell Penetrating Antibodies

We have developed cell penetrating antibodies, which can access the cytosol of living cells following receptor-mediated endocytosis. This unique capability will allow these next-generation therapeutic antibodies to directly target cytosolic proteins associated with many human diseases that have been previously considered untreatable.



Join us to make a difference work on the hardest problem in biologics
delivery to create groundbreaking drugs.